From Biological Insight to a New Class of Medicines for Hemophilia A
0 citations
Abstract
In this Perspective, the 2026 Lasker-DeBakey Clinical Medical Research Award winners describe the development of a bispecific antibody that mimics blood coagulation factor VIII, revolutionizing the treatment of hemophilia, a life-threatening bleeding disorder caused by lack of factor VIII.
// Source
Authors: Kunihiro Hattori, Takehisa Kitazawa, Tomoyuki Igawa
Institutions: Saitama International Medical Center, Osaka Prefectural Toyonaka Support School